Minted: - / 5000

4860 Dipraglurant
389882569f991f306c8983071b1db46efd73165c98030fefabca062ee7ed664c

Properties

Background

Brown
Bottle

Purple
Cap

Red
Syringe

Light green
Bubbles
Yes
Drops
No
Label
-

Chemistry

Formula
C16H12FN3
Carbon
16
Polarity
Neutral

Dipraglurant (INN) (code name ADX-48621) is a negative allosteric modulator of the mGlu₅ receptor which is under development by Addex Therapeutics for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID). As of 2014, it is in phase II clinical trials for this indication. Addex Therapeutics is also investigating an extended-release formulation of dipraglurant for the treatment of non-parkinsonian dystonia.

From Wikipedia, the free encyclopedia. License: CC BY-SA.